Blood-based circulating tumor DNA mutations as a diagnostic and prognostic biomarker for lung cancer.

Maria LeungMaxim B FreidinDaria V FreydinaCharlotte Von CreasePaulo De SousaMonica T BarbosaAndrew G NicholsonEric Lim

Published in: Cancer (2020)

The results of the current study suggested that blood-based ctDNA analysis of cancer mutations is a specific, noninvasive test for the diagnosis of cancer.

Keyphrases

circulating tumor
papillary thyroid
cell free
circulating tumor cells
squamous cell
lymph node metastasis
squamous cell carcinoma